Shanghai Huaota Biopharm
- Biotech or pharma, therapeutic R&D
Huaota Biopharma is a clinical stage biopharmaceutical company committed to discovery, development and commercialization of novel biologics in the cancer and autoimmune therapeutic areas. Our objectives at BIO is to seek global partner(s) to license our current oncology and immunology programs in development, including a PD-L1/VEGF bispecific (for solid tumors), IL-17A/IL-36R bispecific (for HS), and TSLP/IL-11 bispecific (asthma, COPD etc.), and more.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}